Skip to main content

Markers and Immunoprofile of Hepatobiliary Tumors

  • Chapter
  • First Online:
  • 2730 Accesses

Abstract

Please check the hierarchy of the section headings and correct if necessary.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Pan C-C, Chen PC-H, Tsay S-H, Ho DM-T. Differential immunoprofiles of hepatocellular carcinoma, renal cell carcinoma, and adrenocortical carcinoma. A systemic immunohistochemical survey using tissue array technique. Appl Immunohistochem Mol Morphol. 2005;13:347–52.

    Article  CAS  PubMed  Google Scholar 

  2. Koehne de Gonzalez AK, Salomao MA, Lagana SM. Current concepts in the immunohistochemical evaluation of liver tumors. World J Hepatol. 2015;7(10):1403–11.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Lamps LW, Folpe AL. The diagnostic value of hepatocyte paraffin antibody 1 in differentiating hepatocellular neoplasms from nonhepatic tumors: a review. Adv Anat Pathol. 2003;10:39–43.

    Article  PubMed  Google Scholar 

  4. Chu PG, Ishizawa S, Wu E, Weiss LM. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein. Am J Surg Pathol. 2002;26:978–88.

    Article  PubMed  Google Scholar 

  5. Fan Z, van de Rijn M, Montgomery K, Rouse RV. Hep Par 1 antibody stain for the differential diagnosis of hepatocellular carcinoma: 676 tumors tested using tissue microarrays and conventional tissue sections. Mod Pathol. 2003;16(2):137–44.

    Article  PubMed  Google Scholar 

  6. Mac T, Chung F, Lin F, et al. Expression of hepatocyte antigen in small intestinal epithelium and adenocarcinoma. Am J Clin Pathol. 2009;132:80–5.

    Article  PubMed  Google Scholar 

  7. Jeung JA, Coran J, Liu C, et al. Hepatocyte paraffin 1 as a biomarker for early diagnosis of Barrett esophagus. Am J Clin Pathol. 2012;137(1):111–20.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Borscheri N, Roessner A, Röcken C. Canalicular immunostaining of neprilysin (CD10) as a diagnostic marker for hepatocellular carcinomas. Am J Surg Pathol. 2001;25:1297–303.

    Article  CAS  PubMed  Google Scholar 

  9. St Lagana SH, Bao F, et al. Hep Par-1 and Arginase immunohistochemistry in adenocarcinoma of the small intestine and ampullary region. Arch Pathol Lab Med. 2015;139:791–5.

    Article  Google Scholar 

  10. Ordonez NG. Arginase-1 is a novel immunohistochemical marker of hepatocellular differentiation. Adv Anat Pathol. 2014;21(4):285–90.

    Article  CAS  PubMed  Google Scholar 

  11. Timek DT, Shi J, Liu H, Lin F. Arginase-1, Hep par-1 and glypican-3 are the most effective panel of markers in distinguishing hepatocellular carcinoma from metastatic tumor on fine-needle aspiration specimens. Am J Clin Pathol. 2012;138(2):203–10.

    Article  PubMed  Google Scholar 

  12. Lagana SM, Salomao M, Remotti HE, et al. Bile salt export pump: a sensitive and specific immunohistochemical marker of hepatocellular carcinoma. Histopathology. 2015;66(4):598–602.

    Article  PubMed  Google Scholar 

  13. Fujikura K, Yamasaki T, Otani K, et al. BSEP and MDR3 useful immunohistochemical markers to discriminate hepatocellular carcinomas from intrahepatic cholangiocarcinomas and hepatoid carcinomas. Am J Surg Pathol. 2016;40:689–96.

    Article  PubMed  Google Scholar 

  14. Di Tommaso L, Destro A, Seok JY, et al. The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma. J Hepatol. 2009;50(4):746–54.

    Article  PubMed  Google Scholar 

  15. Lagana SM, Salomao M, Bao F, et al. Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma. Appl Immunohistochem Mol Morphol. 2013;21(2):170–6.

    PubMed  Google Scholar 

  16. Surrey LF, Frank R, Zhang PJ, et al. TTF-1 and Napsin are expressed in a subset of cholangiocarcinomas arising from the gallbladder and hepatic ducts. Continued caveats for utilization of immunohistochemistry panels. Am J Surg Pathol. 2014;38(2):224–7.

    Article  PubMed  Google Scholar 

  17. Gütgemann I, Haas S, Berg JP, et al. CD56 expression aids in the differential diagnosis of cholangiocarcinomas and benign cholangiocellular lesions. Virchows Arch. 2006;448:407–11.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Tuffaha, M.S.A., Guski, H., Kristiansen, G. (2018). Markers and Immunoprofile of Hepatobiliary Tumors. In: Immunohistochemistry in Tumor Diagnostics. Springer, Cham. https://doi.org/10.1007/978-3-319-53577-7_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-53577-7_9

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-53576-0

  • Online ISBN: 978-3-319-53577-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics